These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29079678)
1. Mitochondrial DNA density homeostasis accounts for a threshold effect in a cybrid model of a human mitochondrial disease. Aryaman J; Johnston IG; Jones NS Biochem J; 2017 Nov; 474(23):4019-4034. PubMed ID: 29079678 [TBL] [Abstract][Full Text] [Related]
2. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model. Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040 [TBL] [Abstract][Full Text] [Related]
3. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation. Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463 [TBL] [Abstract][Full Text] [Related]
4. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs. Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513 [TBL] [Abstract][Full Text] [Related]
5. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes). Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287 [TBL] [Abstract][Full Text] [Related]
6. The A8296G mtDNA mutation associated with several mitochondrial diseases does not cause mitochondrial dysfunction in cybrid cell lines. Bornstein B; Mas JA; Fernández-Moreno MA; Campos Y; Martín MA; del Hoyo P; Rubio JC; Arenas J; Garesse R Hum Mutat; 2002 Mar; 19(3):234-9. PubMed ID: 11857739 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial disease: mutations and mechanisms. McKenzie M; Liolitsa D; Hanna MG Neurochem Res; 2004 Mar; 29(3):589-600. PubMed ID: 15038606 [TBL] [Abstract][Full Text] [Related]
8. Different effects of novel mtDNA G3242A and G3244A base changes adjacent to a common A3243G mutation in patients with mitochondrial disorders. Mimaki M; Hatakeyama H; Ichiyama T; Isumi H; Furukawa S; Akasaka M; Kamei A; Komaki H; Nishino I; Nonaka I; Goto Y Mitochondrion; 2009 Apr; 9(2):115-22. PubMed ID: 19460299 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Chinnery PF; Samuels DC; Elson J; Turnbull DM Lancet; 2002 Oct; 360(9342):1323-5. PubMed ID: 12414225 [TBL] [Abstract][Full Text] [Related]
10. Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease. Lin DS; Huang YW; Ho CS; Hung PL; Hsu MH; Wang TJ; Wu TY; Lee TH; Huang ZD; Chang PC; Chiang MF Cells; 2019 Jan; 8(1):. PubMed ID: 30658448 [TBL] [Abstract][Full Text] [Related]
11. CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations. Fujita Y; Ito M; Nozawa Y; Yoneda M; Oshida Y; Tanaka M Mitochondrion; 2007; 7(1-2):80-8. PubMed ID: 17276738 [TBL] [Abstract][Full Text] [Related]
12. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA. Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754 [TBL] [Abstract][Full Text] [Related]
13. Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells. Burgin HJ; Lopez Sanchez MIG; Smith CM; Trounce IA; McKenzie M Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244971 [TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Wilkins HM; Carl SM; Swerdlow RH Redox Biol; 2014; 2():619-31. PubMed ID: 25460729 [TBL] [Abstract][Full Text] [Related]
15. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics. Hatakeyama H; Goto Y Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516 [TBL] [Abstract][Full Text] [Related]
16. Interaction theory of mammalian mitochondria. Nakada K; Inoue K; Hayashi J Biochem Biophys Res Commun; 2001 Nov; 288(4):743-6. PubMed ID: 11688969 [TBL] [Abstract][Full Text] [Related]
17. How Far Can Mitochondrial DNA Drive the Disease? Sun H; Shi W; Wang X Adv Exp Med Biol; 2017; 1038():1-8. PubMed ID: 29178065 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial diseases in adults. La Morgia C; Maresca A; Caporali L; Valentino ML; Carelli V J Intern Med; 2020 Jun; 287(6):592-608. PubMed ID: 32463135 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dynamics and aging: Mitochondrial interaction preventing individuals from expression of respiratory deficiency caused by mutant mtDNA. Sato A; Nakada K; Hayashi J Biochim Biophys Acta; 2006; 1763(5-6):473-81. PubMed ID: 16624428 [TBL] [Abstract][Full Text] [Related]
20. New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters. Gajewski CD; Yang L; Schon EA; Manfredi G Mol Biol Cell; 2003 Sep; 14(9):3628-35. PubMed ID: 12972552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]